Abstract Bladder Cancer (BLCa) inter-patient heterogeneity is the primary cause of treatment
failure, suggesting that patients could benefit from a more personalized treatment approach …

Aim: To investigate the prognostic role of neutrophil percentage-to-albumin ratio (NPAR) in
muscle-invasive bladder cancer (MIBC) patients treated with neoadjuvant chemotherapy …

Background: Immune profiles have been associated with bladder cancer outcomes and may
have clinical applications for prognosis. However, associations of detailed immune cell …

Background In contrast to other cancers, the concept of oligometastatic disease (OMD) has
not been investigated in bladder cancer (BC). Objective To develop an acceptable definition …

Importance Low-risk non–muscle-invasive bladder cancer (NMIBC) is associated with
extremely low rates of progression and cancer-specific mortality; however, patients with low …

Context Urothelial carcinoma of the bladder (UCB) exhibits significant sexual dimorphism in
the incidence, etiology, and response to intravesical immunotherapy. Environmental factors …

Simple Summary The mammalian target of rapamycin (mTOR) pathway promotes cell
growth and metabolism in response to growth factors, nutrients, and cellular energy status …

Identifying the histologic subtypes and divergent differentiation in bladder cancer is
important to establish the correct diagnosis and classification and may also be clinically …

Inflammatory cancer-associated fibroblasts (iCAFs) are closely related to progression,
anticancer therapeutic resistance, and poor prognosis of bladder cancer (BCa). However …

The higher incidence of bladder cancer in men has long been attributed to environmental
factors, including smoking. The fact that the sex ratio of bladder cancer remains consistently …